BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chang S, Jain V, Chen T, Patel AS, Pidugu HB, Lin Y, Wu M, Huang J, Wu H, Shah A, Su T, Lee T. Design and Synthesis of 1,2-Bis(hydroxymethyl)pyrrolo[2,1- a ]phthalazine Hybrids as Potent Anticancer Agents that Inhibit Angiogenesis and Induce DNA Interstrand Cross-links. J Med Chem 2019;62:2404-18. [DOI: 10.1021/acs.jmedchem.8b01689] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Sangshetti J, Pathan SK, Patil R, Akber Ansari S, Chhajed S, Arote R, Shinde DB. Synthesis and biological activity of structurally diverse phthalazine derivatives: A systematic review. Bioorganic & Medicinal Chemistry 2019;27:3979-97. [DOI: 10.1016/j.bmc.2019.07.050] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
2 Zheng J, He X, Xu H, Liu H, Yang W. A formal [3 + 2] annulation reaction of propargyl sulfonium compounds and N-ylides: access to pyrrolo[2,1-a]quinolines, pyrrolo[2,1-a]phthalazines and indolizines. Org Biomol Chem 2020;18:8867-75. [PMID: 33094785 DOI: 10.1039/d0ob01739f] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Wang DP, Liu KL, Li XY, Lu GQ, Xue WH, Qian XH, Mohamed O K, Meng FH. Design, synthesis, and in vitro and in vivo anti-angiogenesis study of a novel vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitor based on 1,2,3-triazole scaffold. Eur J Med Chem 2021;211:113083. [PMID: 33340911 DOI: 10.1016/j.ejmech.2020.113083] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Patel AS, Jain V, Rao VN, Lin YW, Shah A, Lai KC, Su TL, Lee TC. Design, synthesis and antitumour evaluation of pyrrolo[1,2-f]-phenanthridine and dibenzo[f,h]pyrrolo[1,2-b]isoquinoline derivatives. Eur J Med Chem 2020;202:112516. [PMID: 32622270 DOI: 10.1016/j.ejmech.2020.112516] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Chen TL, Patel AS, Jain V, Kuppusamy R, Lin YW, Hou MH, Su TL, Lee TC. Discovery of Oral Anticancer 1,2-Bis(hydroxymethyl)benzo[g]pyrrolo[2,1-a]phthalazine Hybrids That Inhibit Angiogenesis and Induce DNA Cross-Links. J Med Chem 2021;64:12469-86. [PMID: 34459195 DOI: 10.1021/acs.jmedchem.0c01733] [Reference Citation Analysis]
6 Shi Z, Wang L, Yang Z, Jie L, Liu X, Cui X. Tandem Construction of Indole-Fused Phthalazines from (2-Alkynylbenzylidene)hydrazines under Metal-Free Conditions. J Org Chem 2020;85:3029-40. [PMID: 32031804 DOI: 10.1021/acs.joc.9b02937] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
7 Antoci V, Moldoveanu C, Danac R, Mangalagiu V, Zbancioc G. Huisgen [3 + 2] Dipolar Cycloadditions of Phthalazinium Ylides to Activated Symmetric and Non-Symmetric Alkynes. Molecules 2020;25:E4416. [PMID: 32992961 DOI: 10.3390/molecules25194416] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 He ZX, Gong YP, Zhang X, Ma LY, Zhao W. Pyridazine as a privileged structure: An updated review on anticancer activity of pyridazine containing bioactive molecules. Eur J Med Chem 2021;209:112946. [PMID: 33129590 DOI: 10.1016/j.ejmech.2020.112946] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Romero AH, Sojo F, Arvelo F, Calderón C, Morales A, López SE. Anticancer potential of new 3-nitroaryl-6-(N-methyl)piperazin-1,2,4-triazolo[3,4-a]phthalazines targeting voltage-gated K+ channel: Copper-catalyzed one-pot synthesis from 4-chloro-1-phthalazinyl-arylhydrazones. Bioorg Chem 2020;101:104031. [PMID: 32629281 DOI: 10.1016/j.bioorg.2020.104031] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]